Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
McKinsey
Teva
US Army
UBS
Accenture
Harvard Business School
Colorcon
Fuji

Generated: August 19, 2017

DrugPatentWatch Database Preview

Nabumetone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nabumetone and what is the scope of nabumetone patent protection?

Nabumetone
is the generic ingredient in two branded drugs marketed by Chartwell Molecules, Mylan Pharms Inc, Dr Reddys Labs Ltd, Apotex Inc, Lupin Ltd, Invagen Pharms, Copley Pharm, Sandoz, Watson Labs, Smithkline Beecham, Impax Labs Inc, and Oxford Pharms, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for nabumetone. Forty-one suppliers are listed for this compound.

Summary for Generic Name: nabumetone

Tradenames:2
Patents:0
Applicants:12
NDAs:13
Drug Master File Entries: see list20
Suppliers / Packagers: see list41
Bulk Api Vendors: see list59
Clinical Trials: see list9
Patent Applications: see list5,993
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nabumetone at DailyMed

Pharmacology for Ingredient: nabumetone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
NABUMETONE
nabumetone
TABLET;ORAL075590-001Feb 25, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
NABUMETONE
nabumetone
TABLET;ORAL078671-001Mar 7, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Copley Pharm
NABUMETONE
nabumetone
TABLET;ORAL075179-001Jun 6, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
NABUMETONE
nabumetone
TABLET;ORAL075189-002Sep 24, 2001ABRXNoYes► Subscribe► Subscribe► Subscribe
Sandoz
NABUMETONE
nabumetone
TABLET;ORAL075590-002Feb 25, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nabumetone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham
RELAFEN
nabumetone
TABLET;ORAL019583-001Dec 24, 1991► Subscribe► Subscribe
Smithkline Beecham
RELAFEN
nabumetone
TABLET;ORAL019583-002Dec 24, 1991► Subscribe► Subscribe
Smithkline Beecham
RELAFEN
nabumetone
TABLET;ORAL019583-001Dec 24, 1991► Subscribe► Subscribe
Smithkline Beecham
RELAFEN
nabumetone
TABLET;ORAL019583-002Dec 24, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Healthtrust
McKinsey
UBS
McKesson
Cantor Fitzgerald
Chinese Patent Office
Medtronic
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot